RefleXion Medical’s SCINTIX biology-guided radiotherapy platform (BgRT) has shined in an observational study involving lung and bone cancer patients. During the US-based PREMIER trial (NCT05406167), ...
HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a therapeutic oncology company, today announced the initial closing of a $105M equity raise, led by The Rise Fund, TPG’s multi-sector global impact ...
HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson ...
Targeted radiotherapy company RefleXion Medical has raised $80 million to help broaden its cancer offerings after recently exploring the company’s potential in treating prostate cancer and other ...
RefleXion Medical is all-in on its biology-guided radiotherapy (BgRT) system—so much so, in fact, that the startup has more than doubled its existing debt to prepare for the technology’s commercial ...
RefleXion announces the scheduled installation of its X1 platform with SCINTIX® biology-guided radiotherapy at Beverly Hills Cancer Center, the first freestanding center to install the X1. SCINTIX ...
We met Reflexion and its Edge screen last year, and even then we were pretty taken with the idea: A Whac-A-Mole-style test for athletes that improves coordination and helps spot concussions after a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results